Publication | Closed Access
Impact of <scp>MET</scp> expression on outcome in <scp>BRAF</scp><sup>V600E/K</sup> advanced melanoma
14
Citations
34
References
2013
Year
MET is expressed in a proportion of BRAF(V600E/K) advanced melanomas. Further analyses on appropriately powered subsets are needed to determine the prognostic and predictive significance of MET in vemurafenib-treated melanoma.
| Year | Citations | |
|---|---|---|
Page 1
Page 1